Interaction of C/EBPα and the glucocorticoid receptor in vivo and in nontransformed human cells

FASEB Journal

Volumn 16, Issue 2, 2002, Pages 177-184

  Rüdiger, Jochen J ^a   Roth, Michael ^a,b   Bihl, Michel P ^a   Cornelius, Bernd C ^a   Johnson, Malcolm ^c   Ziesche, Rolf ^d   Block, Lutz Henning ^d,e  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GLAXOSMITHKLINE   (United Kingdom)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

CCAAT enhancer binding protein alpha; Cell proliferation; Glucocorticoids; Protein complex

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DEXAMETHASONE; DNA; NUCLEAR PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; LEUKOCYTE CULTURE; MESENCHYME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; CELL CYCLE; CELL DIVISION; CELL LINE; CYTOLOGY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETICS; HELA CELL; METABOLISM; PROMOTER REGION; VASCULAR SMOOTH MUSCLE;

VERTEBRATA;

CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEXAMETHASONE; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLUCOCORTICOIDS; HELA CELLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID;

EID: 0036156763     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0226com     Document Type: Article

References (40)

1. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro
2. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I-κB synthesis
3. Glucocorticoid-induced insulin resistance in vitro: Evidence for both receptor and postreceptor defects
4. Glucocorticoids: Mechanisms of action and anti-inflammatory potential in asthma
5. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
6. Nuclear receptor/AP-1 interaction
7. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor
8. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
9. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung
10. STAT3 acts as a co-activator of glucocorticoid receptor signaling
11. Functional interactions between Stat5 and the glucocorticoid receptor
12. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells
13. (waf1/cip1) promoter in rat hepatoma cells
14. (waf1/cip1) gene promoter activity in growtharrested rat hepatoma cells
15. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding proteindependent growth suppression response in a steroid-resistant rat hepatoma cell variant
16. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice
17. CCAAT/enhancer binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein
18. 2-adrenergic receptor agonists in primary, human lung fibroblasts and vascular smooth muscle cells
19. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: Binding sites for hepatocyte nuclear factor-3 and nuclear factor J
20. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix
21. Differences in DNA adduct formation between monocytes and lymphocytes after in vivo incubation with benzo[a]pyrene
22. (W2f1/Cip1), a potential mediator of p53 tumor suppression
23. Topological control of p21(Waf1/Cip1) expression in normal and neoplastic tissues
24. Comparison of plateletderived growth factor prepared from release products of fresh platelets and from outdated platelet concentrates
25. Molecular cloning, sequence, and expression pattern of the human gene encoding CCAAT/enhancer binding protein alpha (C/EBPα)
26. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary, structure
27. DNA binding of the glucocorticoid receptor is not essential for survival
28. Disruption of the C/EBP alpha gene in adult mouse liver
29. Biological role of the CCAAT/enhancer binding protein family of transcription factors
30. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
31. Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators
32. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
33. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma
34. The effect of glucocorticoids on proliferation of human airway smooth muscle
35. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics
36. Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis
37. Proliferative capacity of mononuclear cells in the human lung
38. Essential role of T lymphocytes in the development of allergen-driven airway hyperresponsiveness
39. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid- sensitive and glucocorticoid-resistant chronic asthma
40. A cellular abnormality in glucocorticoid resistant asthma